Clinical Immunoanalyzer Markets

Content

• 1. Overview
  • 1.1 Objectives
  • 1.2 Methodology
  • 1.3 TriMark Publications Report Research and Data Acquisition Structure
  • 1.4 Scope of the Report
  • 1.5 Executive Summary
• 2. IVD Clinical Immunoanalyzer Market
  • 2.1 Introduction
• 3. IVD Clinical Immunoanalyzer Market Analysis
  • 3.1 Markets
    • 3.1.1 Global Markets
    • 3.1.2 Global Drivers of Clinical Immunoanalyzer Testing
    • 3.1.3 Global Outlook
    • 3.1.4 U.S. Market
    • 3.1.5 European IVD Market
      • 3.1.5.1 German Clinical Immunoanalyzer Diagnostic Markets
      • 3.1.5.2 U.K. Clinical Immunoanalyzer Testing Diagnostic Market
      • 3.1.5.3 French Clinical Laboratory Diagnostic Testing Market
      • 3.1.5.4 Italian Clinical Immunochemistry Diagnostic Market
      • 3.1.5.5 Spanish Immunoanalyzer Market
      • 3.1.5.6 Finnish Immunoanalyzer Market
      • 3.1.5.7 Belgian Immunoanalyzer Market
      • 3.1.5.8 Swiss Immunoanalyzer Market
      • 3.1.5.9 Dutch Immunoanalyzer Market
      • 3.1.5.10 Portuguese Immunoanalyzer Market
      • 3.1.5.11 Austrian Immunoanalyzer Market
      • 3.1.5.12 Greek Immunoanalyzer Market
      • 3.1.5.13 Polish Immunoanalyzer Market
      • 3.1.5.14 Romanian Immunoanalyzer Market
    • 3.1.6 Indian Clinical Analyzer Diagnostic Market
      • 3.1.6.1 India?s in vitro Diagnostic Testing Industry
    • 3.1.7 Japanese Clinical Immunoanalyzer Testing Market
    • 3.1.8 Country Clinical Analyzer Smaller Markets
      • 3.1.8.1 China Clinical Analyzer Market
      • 3.1.8.2 Canada Clinical Analyzer Market
      • 3.1.8.3 Brazil Clinical Analyzer Market
      • 3.1.8.4 Turkey Clinical Immunoanalyzer Market
      • 3.1.8.5 Australia Clinical Analyzer Market
      • 3.1.8.6 Rest of the World Clinical Analyzer Testing Market
    • 3.1.9 Overview of Asian Healthcare Market
      • 3.1.9.1 Singapore
      • 3.1.9.2 Malaysia
      • 3.1.9.3 Thailand
      • 3.1.9.4 Indonesia
      • 3.1.9.5 Philippines
      • 3.1.9.6 South Korea
      • 3.1.9.7 India
      • 3.1.9.8 Hong Kong
      • 3.1.9.9 Taiwan
  • 3.2 Clinical Immunoanalyzer Sector
    • 3.2.1 Industry-Served Markets
    • 3.2.2 Industry Players
      • 3.2.2.1 Manufacturing Companies
    • 3.2.3 Market Specialization
    • 3.2.4 Revenue and Reimbursement
    • 3.2.5 Companies
  • 3.3 Outlook for Clinical Immunoanalyzer Testing
    • 3.3.1 Long-Term Changes
    • 3.3.2 Market Drivers
    • 3.3.3 The Limits to Growth
    • 3.3.4 Hot Sectors in IVD Market
    • 3.3.5 Key Technologies
    • 3.3.6 Analyzer Integration Chemistry/Immunoassay
    • 3.3.7 Conclusion
• 4. Clinical Immunoanalyzer Instrument Market by Sector
  • 4.1 Market Analysis: Size, Growth, Share and Competitors
    • 4.1.1 Immunochemistry Analyzers
    • 4.1.2 Large-Volume Immunochemistry Analyzers
      • 4.1.2.1 Abbott Diagnostics
      • 4.1.2.2 Siemens Medical Solutions Diagnostics
      • 4.1.2.3 Beckman Coulter, Inc
      • 4.1.2.4 Dade Behring (Acquired by Siemens)
      • 4.1.2.5 Diagnostics Products Corporation (Acquired by Siemens Healthcare Diagnostics)
      • 4.1.2.6 Olympus America, Inc
      • 4.1.2.7 Ortho-Clinical Diagnostics
      • 4.1.2.8 Roche Diagnostics Corp
      • 4.1.2.9 Tosoh Bioscience
    • 4.1.3 Batch-Type Immunoassay Analyzers
      • 4.1.3.1 Bio-Rad
      • 4.1.3.2 Dade Behring (Acquired by Siemens)
      • 4.1.3.3 Diamedix
      • 4.1.3.4 Tosoh
    • 4.1.4 Small-Volume to Mid-Volume Immunoassay Analyzers
      • 4.1.4.1 Awareness Technology, Inc
      • 4.1.4.2 Siemens Healthcare Diagnostics, Inc
      • 4.1.4.3 Beckman Coulter, Inc
      • 4.1.4.4 bioM?rieux SA
      • 4.1.4.5 Dade Behring (Acquired by Siemens)
      • 4.1.4.6 Randox Laboratories Ltd
      • 4.1.4.7 Tosoh Corporation
    • 4.1.5 Other Immunoassay Analyzers
      • 4.1.5.1 Inverness Medical Professional Diagnostics
      • 4.1.5.2 Hycor BioMedical (A Part of Agilent Technologies)
      • 4.1.5.3 Phadia AB
      • 4.1.5.4 Trinity Biotech PLC
      • 4.1.5.5 Diasorin
      • 4.1.5.6 Grifols U.S.A. Inc
      • 4.1.5.7 Bio-Rad Laboratories, Inc
      • 4.1.5.8 SFRI Diagnostics
      • 4.1.5.9 Qualigen Inc
      • 4.1.5.10 PerkinElmer Inc
      • 4.1.5.11 Innotrac Diagnostics Oy
      • 4.1.5.12 Tecan Group Ltd
• 5. Important Technology Trends
  • 5.1 Technology Innovations in Immunoassay Testing
  • 5.2 Immunoassay Detection Technology Platforms
    • 5.2.1 Fluorescence Detection
    • 5.2.2 Chemiluminescence Detection
  • 5.3 The New Paradigm
  • 5.4 Consolidated Workstations
  • 5.5 Automation in the Laboratory in Response to Labor Shortages
  • 5.6 Laboratory Information System (LIS)
  • 5.7 Biosensor Technology
  • 5.8 Data Management Issues
    • 5.8.1 Wireless LANs
    • 5.8.2 Data and Workflow Management Systems
    • 5.8.3 Beckman Central Command
    • 5.8.4 Advances in Information Management
    • 5.8.5 Connectivity Platforms
    • 5.8.6 DataLink Data Management System
    • 5.8.8 Technical Problems of Connectivity
    • 5.8.9 Web-Based Data Interface and Internet Connectivity
    • 5.8.10 HIT Competition
    • 5.8.11 FDA-Required Software Verification
    • 5.8.12 Advantages of Connectivity
    • 5.8.13 Technologies for Internet-based Remote Architecture
    • 5.8.14 Abbott Multi Tiered Internet System
• 6. Business Trends in Clinical Immunoanalyzer Sector
  • 6.1 Key Developments
  • 6.2 Sector Consolidation
  • 6.3 Diagnostic Testing Growth Trends
  • 6.4 Reagents and Hardware Business in Japan
  • 6.5 New Products
  • 6.6 Acquisitions, License Agreements, Internal Developments and Partnerships
  • 6.7 Product Testing Depth in Clinical Immunoanalyzer Testing
  • 6.8 Government Regulations
    • 6.8.1 U.S. Government Regulations
      • 6.8.1.1 Importing Medical Devices into the U.S
      • 6.8.1.2 Exporting Medical Devices from the U.S
    • 6.8.2 U.K. Regulations
    • 6.8.3 E.U. Regulations
    • 6.8.4 Japanese Regulations
    • 6.8.5 Korean Regulations
  • 6.9 Increased Market Penetration
  • 6.10 Costs of Doing Business in Europe
  • 6.11 Drivers of European Diagnostics Testing
  • 6.12 European Reimbursement Practices
  • 6.13 Cost Containment in Europe
  • 6.14 Medicare Spending Trends/Medicare Part B Spending Trends
• 7. Company Profiles
  • 7.1 Abbott Diagnostics
  • 7.3 Beckman Coulter, Inc
  • 7.4 bioM?rieux
  • 7.5 Dade Behring (Acquired by Siemens)
  • 7.6 Bio-Rad Laboratories, Inc
  • 7.7 Olympus America, Inc
  • 7.8 Ortho-Clinical Diagnostics, Inc
  • 7.9 Phadia AB
  • 7.10 Randox Laboratories Ltd
  • 7.11 Roche Diagnostics Corp
  • 7.12 Tosoh Corporation
  • 7.13 Siemens AG
• 8. Clinical Immunoanalyzer Testing Sector: Trends and Forecasts
  • 8.1 Automated Instrument Platforms Evolution
  • 8.2 Reagents and Supplies Market for Clinical Lab Instruments
  • 8.3 Bar Code Reading
  • 8.4 Measurement and Detection for Immunoassay Analyzers
  • 8.5 Robotics Systems
  • 8.6 Move Away from Central Laboratory
  • 8.7 Modular Automation
  • 8.8 Components of Immunoassay Analyzers
  • 8.9 Drivers of Clinical Immunoanalyzer Testing
  • 8.10 Confluence of New Technology
  • 8.11 New Trends in Clinical Laboratory Testing
    • 8.11.1 Trends in Reimbursement Practices
    • 8.11.2 Managed Care
    • 8.11.3 Changes in Patient Management
    • 8.11.4 Focused Testing
    • 8.11.5 Spending for Clinical Laboratory Testing
    • 8.11.6 Reimbursement Pressure
• 9. Product Launches
  • 9.1 Immunoassay Analyzer Product Launches
  • 9.2 Immunoassay Reagent Product Launches
• List of Tables
  • Table 2.1: Common Immunoassay Tests
  • Table 3.1: Worldwide IVD Testing Market, 2008
  • Table 3.2: Worldwide Distribution of IVD Testing, 2008
  • Table 3.3: Global Clinical Immunoassay Revenues, 2000-2012
  • Table 3.4: Worldwide Distribution of Clinical Immunoassay Testing, 2006
  • Table 3.5: U.S. Clinical Laboratory Testing Market, 2003-2012
  • Table 3.6: U.S. Clinical Laboratory Diagnostic Test Market Segments, 2008
  • Table 3.7: U.S. Individual Clinical Chemistry Laboratory Diagnostic Test Markets, 2007
  • Table 3.8: U.S. Clinical Immunoanalyzer Testing Market, 2000-2012
  • Table 3.9: European Clinical Laboratory Testing IVD Reagents and Instruments Market, 2000-2012
  • Table 3.10: European Clinical Laboratory Testing IVD Reagents and Instruments Market, 2000-2012
  • Table 3.11: European Clinical Laboratory Diagnostic Reagents and Instruments Markets by Analyte, 2008
  • Table 3.12: European Clinical Laboratory Testing Diagnostics by Country Market Estimates, 2007
  • Table 3.13: The European Immunochemistry Market, 2001-2012
  • Table 3.14: European Immunochemical Reagents and Instruments Markets by Country, 2006
  • Table 3.15: German Clinical Laboratory Testing Diagnostics Products Market Sales, 2003-2012
  • Table 3.16: German Clinical Immunochemistry Testing Diagnostics Products Market Sales, 2006-2012
  • Table 3.17: UK Clinical Immunochemistry Testing Diagnostics Products Market Sales, 2006-2012
  • Table 3.18: French Clinical Immunochemistry Testing Diagnostics Products Market Sales, 2006-2012
  • Table 3.19: Italian Immunochemistry Diagnostics Products Market Sales, 2006-2012
  • Table 3.20: Spanish Clinical Laboratory Diagnostics Products Market Sales, 2006-2012
  • Table 3.21: Finnish Clinical Immunoassay Products Market Sales, 2006-2012
  • Table 3.22: Belgium Clinical Immunoassay Products Market Sales, 2006-2012
  • Table 3.23: Swiss Clinical Immunoassay Products Market Sales, 2006-2012
  • Table 3.24: Dutch Clinical Immunoassay Products Market Sales, 2006-2012
  • Table 3.25: Portuguese Clinical Immunoassay Products Market Sales, 2006-2012
  • Table 3.26: Austrian Clinical Immunoassay Products Market Sales, 2006-2012
  • Table 3.27: Greek Clinical Immunoassay Products Market Sales, 2006-2012
  • Table 3.28: Polish Clinical Immunoassay Products Market Sales, 2006-2012
  • Table 3.29: Romanian Clinical Immunoassay Products Market Sales, 2006-2012
  • Table 3.30: Indian IVD Market, 2006-2012
  • Table 3.31: Number of Automated Clinical Labs in India, 2004-2012
  • Table 3.32: Indian IVD Market, 2008
  • Table 3.34: Japanese Clinical Immunoanalyzer Testing Market, 2000-2008
  • Table 3.35: Chinese Clinical Diagnostic Products Market, 2000-2008
  • Table 3.36: Canadian Clinical Analyzer Testing Market, 2000-2008
  • Table 3.37: Brazilian Clinical Immunoanalyzer Testing Market, 2000-2008
  • Table 3.38: Turkish Clinical Analyzer Testing Market, 2000-2008
  • Table 3.39: Australian Clinical Immunoanalyzer Testing Market, 2000-2008
  • Table 3.40: ROW Clinical Immunoanalyzer Testing Market, 2000-2008
  • Table 3.41: Estimated Number of Clinical Laboratories in Latin America
  • Table 3.42: Principal Marketers of Automated Clinical Immunoanalyzer Instruments
  • Table 4.1: Samples and Sample Handling Features of Centaur CP
  • Table 4.2: Large Immunochemistry Analyzers
  • Table 4.3: Small- to Mid-Volume Immunoassay Analyzers
  • Table 5.1: Wireless LAN Technology Companies
  • Table 5.2: Applications for Wireless LAN Technology
  • Table 5.3: CAP and JCAHO Requirements for Customized Reporting
  • Table 6.1: Hospital Laboratory Share of Part B Medicare Spending, 1996-2006
  • Table 6.2: Medicare Part B Spending Per Medicare Enrollee, 1998-2009
  • Table 6.3: Allowed Charges for Top 25 Clinical Laboratory Procedures, 2009
  • Table 8.1: Technology Platforms for Analyzer Detection Systems
  • Table 8.2: Medicare Billing Guidelines for Multi-Channel Immunoanalyzer Tests
• LIST OF FIGURES
  • Figure 6.1: Part B Spending on Clinical Lab Services, 1991 to 2007